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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
COVID-19 Preparedness and Response 
Publication 
date 
Title/URL Journal/Article 
type 
Summary 
28.04.2020 The trinity of 
COVID-19: 
immunity, 
inflammation 
and 
intervention 
Nature 
Reviews 
Immunology | 
Review 
 Understanding the fundamental 
physiological and immunological 
processes underlying the clinical 
manifestations of COVID-19 is vital 
for the identification and rational 
design of effective therapies 
 Therapies targeting the virus and 
controlling the inflammatory 
response may synergise to block 
pathologies at multiple steps 
 Vaccine development and 
evaluation must note the association 
between immune dysfunction and 
outcome of disease severity in 
patients with COVID-19  
 Further studies identifying markers 
of immune correlates of protection 
will help effective triage of patients 
  
2 
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source Description 
30.04.2020 COVID-19 and the Rights of 
Persons with Disabilities: 
Guidance 
UN Human 
Rights 
  
28.04.2020 COVI-PREG CHUV   International COVID-19 and 
Pregnancy   Registry 
28.04.2020 Accessibility Campaign – 
COVID-19 
International 
Disability 
Alliance 
  Call for PH information and 
communications around COVID-
19 to be fully accessible 
24.04.2020 Handwashing compendium 
for low resource settings: a 
living document (edition 1) 
IDS Sanitation 
Learning Hub 
  
Ongoing WHO Country & Technical 
Guidance 
WHO   
Ongoing Rapid guidelines and 
evidence summaries 
NICE   
Ongoing Inter-Agency Standing 
Committee (IASC) 
IASC   
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
28.04.2020 COVID-19 – We urgently need to start 
developing an exit strategy  
Int J Infect Dis | 
Perspective 
Eskild Petersen et 
al. 
30.04.2020 COVID-19’s final frontier: The central 
Africa region 
Travel Med Infect 
Dis 
John Ditekemena 
et al. 
3 
29.04.2020 Keeping COVID-19 at bay in Africa  Lancet Respir 
Med | News 
Munyaradzi Makoni 
26.04.2020 Interdisciplinary perspective on health 
literacy research around the world: 
more important ever in a time of 
COVID-19 
Int J Environ res 
Public Health | 
Editorial 
Tetine Sentell, 
Sandra Vamos & 
Orkan Okan 
30.04.2020 COVID-19 reveals weak health 
systems by design: why we must re-
make global health in this historic 
moment  
Glob Public Health 
| Commentary 
 Sriram 
Shamasunder et al. 
28.04.2020 Pandemic responses: planning to 
neutralize SARS-CoV-2 and prepare 
for future outbreaks 
PLoS Medicine | 
Editorial 
The PLOS 
Medicine Editors 
01.05.2020 Rolling out mass hydroxychloroquine 
prophylaxis for covid-19 in India’s 
slums risk eroding public trust 
BMJ | Opinion  Eejrenab 
Natnayas, Varsha 
Eknath Gaikwad & 
Yogesh Jain 
04.05.2020 COVID-19 mental-health responses 
neglect social realities 
Nature | World 
View 
Rochelle Burgess 
30.04.2020 Covid-19 and domestic violence: 
Caring states? 
ESID | Blog Sohela Nazneen 
04.05.2020 Covid-19: Confidentiality agreements 
allow antibody test manufacturers to 
withhold evaluation results  
BMJ | News 
 
23.04.2020 COVID-19: A global pandemic 
demands a global response 
Georgetown 
University | White 
paper 
Mark Dybul, Robert 
Morello, J Smart, 
Rebecca Katz & 
Peter Piot et al. 
29.04.2020 5 ways NGOs are working with local 
partners to respond to COVID-19 
Bond | News Yolaina Vargas 
Pritchard, Amy 
Shaw 
4 
Tracking Dashboards 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence 
maps 
Current 
studies 
including 
trials 
  Diagnostics  Treatments   Vaccines 
WHO 
sitreps 
WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-2 
Test Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Argumen
ts 
Indonesi
a 
EPPI 
Centre 
WHO 
Internatio
nal 
Clinical 
Trials 
Registry 
Platform 
(ICTRP) 
  Serology-
based tests 
for COVID-
19 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
Europea
n CDC 
Nigeria 
CDC 
Norwegia
n 
Institute 
of Public 
Health 
Cytel     Solidarity 
trial 
  
WEF 
  Sierra 
Leone 
  US NIH     COVID-19 
Therapeutics 
Accelerator 
  
Our World 
in Data 
  Singapor
e 
  COVID-
evidence 
      
Global 
5050 
  UK   Cochrane       
CEBM, 
University 
of Oxford 
  US   Clinicaltri
als.gov 
      
5 
Humanitari
an Data 
Exchange 
              
Information 
is Beautiful 
              
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
  
6 
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Global Health 
Institutes/Centres/Fun
ders/Other 
Health 
Topics 
  Social 
Sciences 
WHO 
COVID-19 
pandemic  
Africa CDC The Lancet LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communicati
on 
African 
Union 
NEJM LSHTM 
 
  IDA 
WHO Q&A Nigeria 
CDC 
Elsevier ICL MRC Centre for 
Global Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability 
and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
BMJ ODI SLH: 
Handwashi
ng in low 
resource 
settings 
  Coregrou
p IDDC 
COVID-19 
Solidarity 
Response 
Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
 
  Rings 
HSG 
Resyst 
Reach 
Wellcome 
UN African 
Academy 
of Sciences 
Cochrane 
resources 
Center for Global 
Development 
    Social 
Developme
nt Direct 
C19 blog 
series 
UN Women Africa 
Evidence 
Network 
PLoS CMMID Repository     
UNOCHA   Annals of 
Internal 
Medicine 
Norwegian Institute of 
Public Health 
    
7 
UNHCR     Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF      HEART     
UNESCO   Wiley 
Health 
Economics 
 UKRI     
UN WFP   Pre-prints 
medRxiv 
and 
bioRxiv 
 Evidence Aid     
GOARN           
EPI-WIN           
World Bank           
COVID-19 
Narratives by 
David 
Nabarro 
          
Reliefweb           
Humanitarian 
OpenStreetM
ap Team 
          
Global 
Partnership 
for 
Sustainable 
Development 
Data 
          
WorldPop           
8 
Flowminder           
COVID-END           
Premise 
COVID-19 
Global 
Impact Study 
    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online learning 3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-
time training for the 
coronavirus disease 
outbreak 
Online learning Multiple self-
paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel 
Coronavirus 
Online learning 3 weeks | 4 
hours 
weekly study 
FutureLearn LSHTM/UK 
PHRST 
20 April 
2020 
COVID-19 
Diagnostics and 
Testing 
Online learning 3 weeks | 3 
hours 
weekly study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 
2020 
COVID-19 Critical 
Care: Understanding 
and Application 
Online learning 5 weeks | 1 
hour weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians of 
Edinburgh  
9 
Available 
now 
COVID-19 
supporting online 
courses 
Online learning Multiple self-
paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
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